As a Data Scientist at Oracle Health, you are at the intersection of complex healthcare data and actionable clinical insights. Your work is fundamental to refining the digital infrastructure that providers, health systems, and patients rely on daily. You will be tasked with transforming massive, often unstructured, healthcare datasets into predictive models and analytical frameworks that improve operational efficiency and patient outcomes.
This role requires a unique blend of technical rigor and product intuition. You will not only build sophisticated models but also define the metrics that govern product success, diagnose shifts in system performance, and design experiments to validate new features. Because Oracle Health operates at a massive scale, your contributions directly influence the reliability and intelligence of clinical software, making this a high-impact position for those who thrive on solving complex, real-world problems.
Recruiter Screening
reportedWhoever runs this call is usually not a practitioner. They take notes, and a hiring manager skims those notes later, so the real question is whether your work survives being written down by someone outside the field. Test every project sentence against that: could a non-specialist repeat it correctly without knowing what a propensity score is? Carry a plain-language version of each project and one reason you want this particular role that you could not copy onto another application. Vagueness at this stage reads as inexperience, even when the underlying work was genuinely deep.
What to demonstrate
- Whether a non-specialist can restate your projects accurately, since their paraphrase is what reaches the hiring manager
- Whether your reason for wanting the role points at the work itself rather than the company's reputation
- Whether your language signals the level being screened for: what you decided yourself versus what you were handed
How to prepare
- Write a two-sentence, jargon-free version of each major project: the question nobody could answer, and the decision your work changed. Read it to someone outside data and have them repeat it back
- Point your 'why this role' answer at something concrete in the job description or the product surface you would be working on, and keep it to two sentences
- Have two questions ready about measurement: which metric the team is held to, and who acts on an analysis once it lands
Technical Assessments
reportedMuch of what gets scored here happens out loud while you type. Nobody can see your reasoning inside a half-written query, so five silent minutes read as being stuck even when they are not. State the plan in plain language first: which tables, what grain you are aggregating to, and the one filter that defines the population. Then write it. The narration doubles as insurance, because a wrong plan gets caught early and cheaply while a wrong query gets caught at the end with no time left to redo it. A timed statistics section, where one exists, is a separate test with its own clock.
What to demonstrate
- Whether the query you write matches the plan you just described
- What you do with a hint, meaning whether the correction gets absorbed or the first approach gets defended
- Whether you can debug your own wrong output by reading the result set and naming which part of the query produced the anomaly
How to prepare
- Solve three problems while screen-sharing into a recording, then watch it back and mark every stretch longer than thirty seconds where you said nothing
- Practise compressing the plan into one sentence before typing, then check afterwards whether the finished query actually matched it
- Time yourself on statistics questions that carry a business reading, such as what a confidence interval does and does not claim, rather than re-reading notes without a clock
Behavioral Sessions
reportedMost of the weight in this round sits on the disagreement questions. Data work routinely produces an answer someone senior did not want, and the interviewer is trying to learn what you do in that hour. Both failure modes are common: folding as soon as a director pushes back, and treating the pushback as ignorance to be corrected with a better chart. A strong answer usually contains a specific thing the other person knew that you did not, and describes how you found out whether it changed the conclusion.
What to demonstrate
- Whether you can state the other side's argument accurately before you explain why you disagreed
- What you treated as evidence during the disagreement, such as a rerun under their assumption or a holdout check, rather than persuasion technique
- Whether you distinguish being overruled from being wrong, and can give an example of each
How to prepare
- Write out one disagreement where you turned out to be wrong, and say what in the data misled you. Candidates prepare the story where they were right, and the follow-up asks for the other one.
- For your main disagreement story, be ready to say what result would have made you drop your position. If no such result exists, you were not arguing from the data.
- Practise stating the opposing position out loud in one sentence the stakeholder would accept, then continue the story.
Final Round Panels
reportedA loop is not scored one interview at a time. The people you meet compare notes afterwards, usually in a meeting you are not in, and the outcome turns on what each of them can say about you when asked. That rewards something other than survival: every room needs one specific thing worth repeating, and none of them can contradict another. The common way to lose is to tell the same project four times with different numbers in it, or to be uniformly fine in a way that leaves nobody with anything to argue for.
What to demonstrate
- Whether your account of a project survives being told twice, with the same scale, the same metric definition and the same numbers each time
- Whether each interviewer leaves with one concrete claim they could make on your behalf later, rather than an absence of complaints
- Whether a question you already answered in an earlier room gets the same answer at the same depth, without visible impatience
How to prepare
- Write a one-page fact sheet for your two or three main projects that fixes the numbers you will quote: rows of data, the metric as a single sentence, the effect you measured and how long the work took. Say them aloud from the sheet until they come out identical every time
- For each kind of room you expect, decide the one sentence you want that interviewer repeating in a debrief, then check during the mock that you said it outright instead of implying it
- Rehearse answering the same project question twice in one sitting, the second time as though you had not just answered it, because the thing that needs fixing is the flatness that creeps into a repeated story
PracHub editorial advice for the preparation topics above.
Reading the most recent months of a claims-based series as real
Claims incur before they are reported and paid, so recent incurred months are systematically undercounted until runout completes. The lag is not uniform: pharmacy adjudicates in days, professional claims in weeks, inpatient facility claims in months. That means recent data is both too low and mix-shifted toward cheap services, which reads as a cost improvement and a utilisation drop at once. The fix is to hold the last three incurred months back or apply completion factors, and to state the paid-through date on every chart.
Ignoring clustering by provider, facility, or site
Patients within a provider panel, and subjects within a trial site, are correlated on both case mix and practice pattern. Standard errors computed as if observations were independent are too narrow by roughly the design effect, 1 + (m - 1) * ICC, where m is the average cluster size. With 50 patients per provider and an intracluster correlation of only 0.02, variance is understated by about a factor of two, which manufactures significant provider differences out of noise. Cluster-robust errors or a random intercept per provider, and cluster-level randomisation when you design the test, are the corrections.
Defining the cohort on a post-treatment condition
Ask how rows entered the table. Filtering on something that treatment itself influences, such as users who finished onboarding or accounts still active at ninety days, breaks comparability between arms; define the population at an entry point that precedes exposure and keep everyone in it.
Sizing estimates built on unnamed, unrevisable assumptions
Write each assumption as a named number you can change, then show the arithmetic so the interviewer can challenge one input instead of the whole answer. Finish by saying which assumption the result is most sensitive to, which matters more than the point estimate.
Choose a category, try a prompt, then open its approach, worked solution or follow-up when you need it.
Explain the concept of P-values and confidence intervals to a non-tech…
Explain the concept of P-values and confidence intervals to a non-technical stakeholder.
Approach
- Write down the assumption the method needs before you use the method.
- Sanity-check the answer against a simple bound or a simulated case.
- Say what the estimate is of, and over what population it generalises.
Follow-up
- How would you explain this result to someone who does not know statistics?
- What sample size would you need to detect an effect half this size?
How do you approach the "cold-start" problem in a recommendation syste…
How do you approach the "cold-start" problem in a recommendation system?
Approach
- Frame the prediction: the label, the moment of prediction, and the action it triggers.
- Pick an evaluation metric that matches the cost of each error type, not a default.
- Check what information would not exist at prediction time, and exclude it.
Follow-up
- What would you monitor after launch to know the model is still valid?
- Where could label leakage enter this setup?
Expand overlapping coverage spans into fractional member-months
member_enrollment has span_id, member_id, plan_id, product_type, effective_date, termination_date (NULL while active). Both dates are inclusive. Write a function returning one row per calendar month of a stated year with total member-months, where a member contributes covered days in the month divided by days in that month, capped at one month per member even when two spans overlap after a plan change or a retroactive span. Do not expand to one row per member-day: the sample has 400,000 members. Output: month, member_months.
Approach
- Resolve NULL termination_date to the reporting end date and say so in a comment. An open span is not an infinite span, and clipping it at the year end is what keeps the denominator finite and auditable.
- Merge overlapping and adjacent spans per member before touching months. Sort by member_id and effective_date, carry a running maximum of the end date, and open a new merged group when effective_date exceeds that running max plus one day. Adjacent means a gap of zero days, which a plan change produces constantly.
- Cross join the merged spans to the 12 month boundaries rather than to days. Overlap days = (min(span_end, month_end) - max(span_start, month_start)).days + 1, clipped below at 0. That is at most 12 rows per span instead of 365.
- Divide overlap days by the number of days in that month, so February and July are weighted correctly, then sum by month.
- Validate on a constructed member before trusting the aggregate: a single span covering the whole year must sum to exactly 12.0.
Worked solution 30 min
- Fill termination_date nulls with the reporting end date and clip all spans to the reporting year.
- Sort by member_id, effective_date, then compute a running max end per member with cummax shifted by one, flag a new group where effective_date > prior_max_end + 1 day, and cumsum the flag to get merged group ids.
- Aggregate each group to min start and max end, producing disjoint spans per member.
- Cross join merged spans to a 12-row month frame, compute clipped overlap days, divide by days in month.
- Group by month and sum.
Follow-up
- Product type changes mid-year. The metric must be reported by product_type. Where does the cap now apply and what breaks?
- An eligibility file arrives with a retroactive termination that shortens a span you already reported on. How do you restate?
- Why member-months rather than distinct members, in one sentence, for a director who wants the simpler number?
Explain the difference between `RANK` and `DENSE_RANK` and when you wo…
Explain the difference between RANK and DENSE_RANK and when you would use each.
Approach
- Check whether any join is one-to-many before aggregating, or the sums inflate.
- Handle the rows that do not match: a LEFT JOIN with a NULL check is usually the question.
- State the window function and its partition and ordering out loud before writing it.
Follow-up
- How would you verify this result without re-running the same query?
- How does the query change if the join becomes one-to-many?
Given a table of patient encounters, how would you calculate a rolling…
Given a table of patient encounters, how would you calculate a rolling average of wait times?
Approach
- Check whether any join is one-to-many before aggregating, or the sums inflate.
- Say which table is the grain you start from, and join outward from it.
- Handle the rows that do not match: a LEFT JOIN with a NULL check is usually the question.
Follow-up
- What breaks if events arrive late or out of order?
- How does the query change if the join becomes one-to-many?
Reconstruct drug coverage intervals and compute proportion of days covered
pharmacy_claim holds fill_id, member_id, ndc_code, therapeutic_class_code, fill_date, days_supply, reversal_flag and reversed_fill_id. Early refills overlap, so days_supply must be laid end to end: each fill's coverage starts at the later of its fill_date and the previous interval's end. Both rows of a reversed pair are excluded. For one therapeutic_class_code over 2025-01-01 to 2025-06-30, return per member the proportion of days covered, defined as covered days divided by days from first fill_date to window end, plus the share of members at or above 0.80. Require at least two fills and 91 days of follow-up.
Approach
- Clean the fills first. Drop rows with reversal_flag TRUE and also the fills they point at through reversed_fill_id. Dropping only the reversal row leaves an original fill counted as exposure that never reached the member. Use NOT EXISTS for that second step, since reversed_fill_id is nullable and NOT IN would return nothing.
- Shift, never stack. The shifted end is covered_end_i = GREATEST(fill_date_i, covered_end_{i-1}) + days_supply_i, which looks recursive but has a closed form: with cum_i the running sum of days_supply through fill i, covered_end_i = cum_i + MAX over j <= i of (fill_date_j - cum_{j-1}). That is SUM(days_supply) OVER (ORDER BY fill_date ROWS UNBOUNDED PRECEDING) plus a running MAX of an anchor column, so it is two window functions and no recursive CTE.
- Derive covered_start_i as GREATEST(fill_date_i, LAG(covered_end)). The intervals are disjoint by construction, so covered days is a plain sum of lengths and never needs a distinct day grid.
- Clip intervals to the window end before summing, and decide explicitly whether to clip at disenrollment as well. Supply that runs past the window must not inflate the numerator.
- Use the denominator the spec names, first fill_date to window end, and hold it constant across classes. A fixed-window denominator yields a different and usually lower number, and mixing the two across classes makes the comparison meaningless.
- Apply the inclusion rules at member level after the intervals are built, then compute the share at or above 0.80 with the qualifying member count beside it.
Worked solution 40 min
- Filter to the therapeutic_class_code and window, then remove reversal rows and their originals with NOT EXISTS.
- Per member ordered by fill_date, compute cum_supply and anchor = fill_date - (cum_supply - days_supply), then covered_end = cum_supply + MAX(anchor) OVER (ORDER BY fill_date ROWS UNBOUNDED PRECEDING).
- Compute covered_start = GREATEST(fill_date, LAG(covered_end) OVER (ORDER BY fill_date)), clip both ends to the window, and drop intervals that collapse.
- Sum interval lengths as covered_days, compute follow_up_days from first fill_date to window end, and divide.
- Apply the two-fill and 91-day rules, then aggregate the share at or above 0.80.
Follow-up
- A member is hospitalised for twelve days mid-window, when the facility supplies medication. Should those days count as covered, and what do published adherence measures do about them?
- Someone wants to classify adherence over twelve months and then compare mortality from month zero. What is wrong with that design and what fixes it?
- Two different ndc_codes in the same therapeutic class overlap. Is that stacking or switching, and how does your interval logic treat each case?
A key engagement metric for our provider portal dropped by 10% overnig…
A key engagement metric for our provider portal dropped by 10% overnight. How would you investigate the root cause?
Approach
- State what result would change your recommendation, so the answer is falsifiable.
- Restate the decision this analysis has to support, and who acts on the answer.
- Fix the population and the time window before naming any metric.
Follow-up
- Which segment would you cut first, and what would that rule out?
- How would you detect that the metric is being gamed rather than genuinely improving?
If you were tasked with improving the recommendation system for physic…
If you were tasked with improving the recommendation system for physician workflows, what signals would you prioritize?
Approach
- Fix the population and the time window before naming any metric.
- State what result would change your recommendation, so the answer is falsifiable.
- Restate the decision this analysis has to support, and who acts on the answer.
Follow-up
- Which segment would you cut first, and what would that rule out?
- What would you do if the primary metric and the guardrail moved in opposite directions?
How would you design a metric to track the accuracy of patient data en…
How would you design a metric to track the accuracy of patient data entry?
Approach
- Name one primary metric, then the guardrail that stops it being gamed.
- Decompose the metric into the rates that drive it, and say which one you would check first.
- Fix the population and the time window before naming any metric.
Follow-up
- Which segment would you cut first, and what would that rule out?
- What would you do if the primary metric and the guardrail moved in opposite directions?
How would you measure the success of a new clinical decision support f…
How would you measure the success of a new clinical decision support feature?
Approach
- Decompose the metric into the rates that drive it, and say which one you would check first.
- Restate the decision this analysis has to support, and who acts on the answer.
- Name one primary metric, then the guardrail that stops it being gamed.
Follow-up
- How would you detect that the metric is being gamed rather than genuinely improving?
- What would you do if the primary metric and the guardrail moved in opposite directions?
If you have a low sample size, how do you adjust your testing strategy…
If you have a low sample size, how do you adjust your testing strategy?
Approach
- Name the randomisation unit first; it decides the variance and what the test can detect.
- Name the guardrails that would stop a launch even on a positive primary result.
- Decide the analysis before seeing data, including how long it runs and when you look.
Follow-up
- What would you conclude if the result is positive but the test is underpowered?
- How would you handle interference between treated and control units?
How do you determine if a result is statistically significant?
How do you determine if a result is statistically significant?
Approach
- Say whether units interfere with each other, and switch design if they do.
- Name the randomisation unit first; it decides the variance and what the test can detect.
- State the primary metric and the minimum effect worth shipping, then size the test.
Follow-up
- What would you do if you could not randomise at all?
- What would you conclude if the result is positive but the test is underpowered?
Evaluate a book-wide benefit change with no untreated members
On 1 January a therapeutic class moves from formulary tier 2 to tier 3, raising member cost share, for the entire commercial group book at once. No untreated subset of that book exists. You have 36 months of pharmacy_claim and member_enrollment covering that book plus the Medicare Advantage and Medicaid managed books, which are unaffected. Outcomes are class fills per 1,000 member-months and the share of members with PDC at or above 0.80. Give the design, the identifying assumption, and how you would test it.
Approach
- Rule out the single-series interrupted time series first and say why. The change lands on 1 January, which is also when deductibles reset, benefit designs change, and members switch plans, so a level shift at the new year is confounded with the entire annual benefit cycle. Any design that cannot separate those two is not usable here.
- Build an event-study difference-in-differences with the unaffected product books as controls, estimating month-by-month coefficients relative to December. The lead coefficients are the test of the identifying assumption, not decoration: they should be indistinguishable from zero, and you should say in advance what magnitude of lead violation would make you abandon the design.
- State what the control books are doing for you and what they are not. They experience the same January reset, which is precisely why they are useful, but they differ in population age, cost-sharing structure, and eligibility churn, so parallel counterfactual trends is a real assumption and residual confounding should be named rather than waved at.
- Add a synthetic control as the robustness check: construct a weighted combination of donor series (other product books crossed with other therapeutic classes) that tracks the treated series through the pre-period, and do inference by permutation, assigning the intervention to each donor and comparing post-to-pre RMSPE ratios. Require that the treated pre-period sits inside the convex hull of the donors, and abandon the approach if pre-period fit is poor.
- Fix the population before estimating anything. If the tier move pushes members out of the book, the post-period population differs from the pre-period one, so restrict to members continuously enrolled across the window with a stated allowable gap, and report sensitivity to that gap. Note that pharmacy claims adjudicate in days, so unlike a medical-cost series this outcome is essentially complete within weeks.
Worked solution 45 min
- Build a monthly panel of fills per 1,000 member-months and PDC share by product book, restricted to members continuously enrolled across the window with a 45-day allowable gap.
- Plot the treated and control series for 24 pre-period months and inspect visually before fitting anything.
- Estimate an event-study DiD with month-relative-to-January coefficients, product fixed effects, and calendar-month fixed effects, clustering standard errors at the product-book level or higher.
- Run the placebo: re-estimate as if the change happened on the prior 1 January, which isolates the annual reset from the tier move.
- Fit a synthetic control on donor product-class series, check pre-period RMSPE, and run the permutation inference across donors.
Follow-up
- The lead coefficients are not flat: the treated book was already drifting down for six months. What do you do without abandoning the question?
- Therapeutic substitution is expected. How do you tell a true reduction in therapy from members moving to a cheaper drug in the same class?
- How would you report the result so a clinical committee can act on it, given that fills per 1,000 member-months is not an outcome anyone treats?
Pooled persistency fell but no one lost coverage
Pooled 12-month enrollment persistency fell from 0.78 to 0.66 for the cohort anchored in a single month. member_enrollment carries span_id, member_id, plan_id, product_type, effective_date, termination_date, termination_reason_code, dual_eligible_flag and region_code. The metric allows at most one gap of 45 days or fewer. Product mix in that anchor month was not stable. Determine how much of the fall is real disenrollment rather than span bookkeeping or mix, and deliver a persistency series a contract owner could act on.
Approach
- Inspect the query's unit of analysis first. Spans are not members, and a benefit or plan change closes one span and opens the next on the same day, so any logic that treats a non-null termination_date as loss of coverage counts an administrative event as churn.
- Rebuild member-level coverage by unioning all spans per member and merging adjacent or overlapping ones, then apply the 45-day gap rule to the merged intervals rather than per span.
- Cut the terminations by termination_reason_code. plan_change and eligibility_redetermination have entirely different meanings for a contract, and death is not churn you can address.
- Split by product_type and stop pooling. Commercial open enrollment and managed medicaid redetermination produce structurally different churn on different calendars, and the pooled average of the two is a number that describes nobody.
- Compare the anchor month to the same month in the prior year rather than to the adjacent month, because enrollment is strongly seasonal and an anchor month sitting on an open-enrollment or redetermination boundary is not comparable to its neighbour.
- Apply the Kitagawa decomposition across product_type to separate how much of the 12 point fall is mix, meaning the anchor cohort simply contained more of a high-churn product, from how much is within-product deterioration.
Follow-up
- Why 45 days, and what would change if the allowable gap were 30 or 60?
- A member terminates and re-enrolls 90 days later under a different plan_id. Are they retained? Defend your answer against the opposite one.
- What guardrail would catch someone improving persistency by declining to enroll members likely to churn?
For a candidate whose interviews will centre on A/B testing, metric movement and causal claims. Design comes before arithmetic, arithmetic before analysis, and the week ends by rehearsing the readout rather than the derivation.
Prepare, practise & reflect
One practical outcome each day. Spend longer where you need it.
0 / 7 done01Design one test end to end on paper
- Take a single feature change and write the full design: randomization unit, the exact point of exposure, the primary metric with its grain, guardrails, allocation, planned duration, and the decision rule committed before any data exists.
- Write why the randomization unit must sit at or above the level where treatment can spill over, and give one case where user-level randomization is still contaminated (shared accounts or devices, or two participants in the same marketplace).
- State in advance what you will do if the primary metric is flat while a secondary metric is significant.
Deliverable: A one-page test design with a decision rule written before launch.
Practice prompt ↗Practice prompt ↗Practice prompt ↗Worked solution ↗02Power arithmetic until it is automatic
- Compute required sample size per arm for a binary metric with the normal approximation, n is approximately 2 times (z for alpha/2 plus z for power) squared times p(1 minus p) divided by delta squared, for baselines of 2, 10 and 40 percent at a 5 percent relative lift, and note that for a fixed relative lift the requirement falls as the baseline rises because delta grows proportionally with p.
- Redo the calculation for a continuous metric using variance in place of p(1 minus p), and show why a heavy-tailed quantity such as revenue per user needs either far more traffic or a capped version with a stated cap.
- Convert one of the results into weeks given a weekly eligible traffic figure, then list the two honest ways to shorten it (accept a larger detectable effect, or reduce variance) and write why quietly lowering the power target is a decision to miss more real wins, not a speedup.
Deliverable: A small script or sheet that maps baseline, minimum detectable effect, alpha and power to sample size and weeks, cross-checked against a published calculator.
Practice prompt ↗Practice prompt ↗Practice prompt ↗03Variance and the unit-of-analysis problem
- Take a ratio metric whose denominator is not the randomization unit (clicks per session, randomized by user) and compute the standard error twice, once naively at session level and once by the delta method or a user-level bootstrap, then record how much the naive version understates it.
- Implement CUPED on simulated data: choose a pre-period covariate X measured before assignment, estimate theta as Cov(Y, X) divided by Var(X), and analyse Y minus theta times (X minus its mean) in place of Y. Confirm the variance of the adjusted outcome equals the raw variance multiplied by one minus the squared correlation between Y and X, so a correlation of 0.45 removes about 20 percent of the variance and not 80.
- Now run that simulation a few hundred times and confirm the adjusted effect estimate is unbiased for the same effect rather than numerically identical to the raw one. Within any single run the two differ, sometimes by a large fraction of the true effect, because the two arms' pre-period covariate means never coincide exactly in a finite sample; they agree in expectation, which is the property that matters and the one to state out loud.
Deliverable: A notebook showing the adjusted estimator with a measurably smaller variance than the raw one, plus a repeated-simulation table showing the two estimators agreeing on average while differing run by run.
Practice prompt ↗Practice prompt ↗Practice prompt ↗04Validity threats you can actually test for
- Run a sample ratio mismatch check as a chi-square goodness-of-fit test against the intended allocation, and write the three causes you would chase first (assignment logged before exposure, an arm-specific redirect or load failure, bot filtering applied asymmetrically).
- Simulate peeking: generate A/A data, test daily at alpha 0.05 across 14 looks, record the inflated false positive rate, then apply an alpha-spending boundary or commit to a fixed horizon and confirm the rate returns to nominal.
- Write how you would separate a novelty effect from a durable lift using the treatment effect plotted against days since first exposure, and what shape would change your recommendation.
Deliverable: One table showing the peeking false positive rate before and after correction, plus a written SRM triage list.
Practice prompt ↗Practice prompt ↗Worked solution ↗05When randomization is not available
- Write the identifying assumption for difference-in-differences (parallel trends in the absence of treatment), then plot pre-period trends for two candidate control groups and justify rejecting one of them.
- Design a switchback test for a change where user-level randomization would leak across participants, choosing a time-block length against the carryover you expect and saying how you would detect carryover in the data.
- List what an interrupted time series or a synthetic control buys you and the one thing neither can rule out: an unobserved shock that coincides with the launch.
Deliverable: A one-page memo recommending a single quasi-experimental design and naming its weakest assumption explicitly.
Practice prompt ↗Practice prompt ↗06The readout query
- Write the assignment-to-exposure join that returns exactly one row per unit per experiment, and handle units appearing in both arms by excluding and counting them rather than silently keeping one.
- Compute the per-arm metric, its variance and the relative lift with a confidence interval in SQL, then reproduce the identical numbers in a notebook as a cross-check.
- Add a segment breakdown and write the sentence that keeps it from being p-hacking: segments declared in advance, everything else reported as exploratory and corrected for multiplicity.
Deliverable: A single query that outputs the full readout table, matched to a notebook recomputation.
Practice prompt ↗Practice prompt ↗07Present it to someone who will not read the appendix
- Give a 10-minute readout of a real or simulated experiment in the order decision, number, uncertainty, caveat.
- Have your listener ask "can we ship it" in the case where the primary is flat and a guardrail moved, and answer with a recommendation rather than a request for more data.
- Rewrite your opening line so the recommendation lands before any methodology.
Deliverable: A one-page readout whose first line is the recommendation.
Practice prompt ↗Practice prompt ↗Worked solution ↗Expand any day for tasks and deliverables. Your progress is saved on this device.
Work that nobody used is a common and unflattering pattern in data careers, and interviewers probe for it. Have a story about an analysis that changed a decision, and be specific about how you got it in front of the person who could act. Also have one about work that went nowhere, with your reading of why.
How do you handle outliers when calculating mean and variance for clin…
How do you handle outliers when calculating mean and variance for clinical datasets?
Approach
- Close with what you would do differently, concretely.
- State the situation in two sentences and spend the rest on your reasoning.
- Name the disagreement or constraint, and how you resolved it with evidence.
Follow-up
- How did you know the outcome was caused by your change?
- What did you decide not to do, and why?
Own an analysis that shipped wrong and was acted on
Describe an analysis you delivered that was wrong, where someone acted on it before the error surfaced. Pick something with a mechanism you can name, not a typo. Cover what the number claimed, what was actually true, how much time passed before it was caught, who caught it, and what you told the people who had already acted. Deliverable: a five-minute account that ends with the specific control you added afterwards, plus one occasion since when that control has fired.
Approach
- Read the probe: the interviewer is testing whether you detect your own errors and whether the correction was structural. Pick an error with a nameable mechanism (a denominator built from distinct members instead of member-months, a series read before claims runout completed, a cohort selected on the outcome) so the story has a diagnosis rather than a mood.
- Open with the decision that was made on your number, not with the bug. The severity of an analytic error is measured in the action it caused: a rate filing, a staffing plan, a programme expansion.
- State the counterfactual number. 'The true figure was 14.1 admissions per 1,000 member-years, not 9.8' is a fact; 'it was off by a lot' is not.
- Describe the detection path honestly, including whether you found it or somebody else did. Say how long it took, because time to detection is the part you actually control next time.
- Close on the control, and make it something that protects a reader who has never met you: a unit test on the denominator, a paid-through date stamped on every chart, a required exclusions block in the spec template. Name one later date it caught something.
Follow-up
- What would have had to be true for you to catch this before delivery rather than after?
- Did the stakeholder change how much they trust your work, and did you want them to?
- Give an example of a control you added that turned out to be the wrong control.
Explain an incomplete cost series to a non-technical executive
An executive opens a dashboard showing risk-adjusted allowed PMPM down 6 percent across the last three incurred months and asks whether the cost initiative is working. You know pharmacy adjudicates within days, professional claims within weeks, and inpatient facility claims over months, so those three months are both undercounted and mix-shifted toward cheap services. There is also a genuine movement of roughly 1.5 percent in the older, complete months. Deliverable: a two-minute spoken answer, the change you make to the chart, and what you commit to telling them and when.
Approach
- The probe is whether you can be honest about uncertainty without sounding evasive. Executives read hedging as not knowing, so the answer has to end in a commitment.
- Separate the two claims immediately. The 6 percent is an artefact of incomplete data, and there is a smaller real movement in the months that are complete. Delivering only the debunk leaves them holding nothing.
- Explain the lag in their terms: the bills for the most expensive care arrive last, so an incomplete month always looks cheap and always looks like it is improving. Keep the phrase completion factor out of the first pass.
- Fix the chart instead of explaining around it. Shade or omit the incomplete months, print the paid-through date on the axis, and overlay the same series as it looked at equivalent maturity a year earlier so the shape is comparable rather than merely lower.
- Close with a date and a magnitude. Commit to a restated figure once runout matures, say roughly how far you expect the 6 percent to shrink, and name what you would need to see to call the initiative working.
Follow-up
- They ask for your best guess today, knowing it is provisional. What do you say?
- The restated number comes back at 1 percent. How do you handle having flagged the 6 percent at all?
- How do you stop this dashboard producing the same conversation next quarter?
- 01
How do you handle outliers when calculating mean and variance for clinical datasets?
- 02
Describe an analysis you delivered that was wrong, where someone acted on it before the error surfaced. Pick something with a mechanism you can name, not a typo. Cover what the number claimed, what was actually true, how much time passed before it was caught, who caught it, and what you told the people who had already acted. Deliverable: a five-minute account that ends with the specific control you added afterwards, plus one occasion since when that control has fired.
- 03
An executive opens a dashboard showing risk-adjusted allowed PMPM down 6 percent across the last three incurred months and asks whether the cost initiative is working. You know pharmacy adjudicates within days, professional claims within weeks, and inpatient facility claims over months, so those three months are both undercounted and mix-shifted toward cheap services. There is also a genuine movement of roughly 1.5 percent in the older, complete months. Deliverable: a two-minute spoken answer, the change you make to the chart, and what you commit to telling them and when.
Is this an official Oracle Health interview guide?
No. It is PracHub's own research and practice material for the Data Scientist role at Oracle Health. Rounds and questions reflect what candidates have reported, not a process Oracle Health has published, and they change over time. Confirm the current format and scope with your recruiter.
PracHub interview research ↗How difficult are the technical interviews?
The technical bar is high. Expect to be challenged on your fundamental understanding of statistics and your ability to write clean, production-ready SQL.
PracHub interview research ↗What is the best way to prepare for the project presentation?
Focus on the "why." Explain the problem you were trying to solve, the trade-offs you made in choosing your methodology, and the ultimate impact of your work on the business or user.
PracHub interview research ↗How long does the process usually take?
The timeline can vary, but expect a multi-week process that includes several rounds of interviews. Stay patient and maintain consistent communication with your recruiter.
PracHub interview research ↗Does the company value remote work?
Oracle Health has varying policies based on the specific team and location. It is best to clarify this during your initial recruiter screen.
PracHub interview research ↗Sources & methodology 3 sources ↗
No official company page is cited. Rounds and questions come from candidate reports and PracHub editorial material; each source shows the date it was read.
- 01PracHub interview research ↗
PracHub editorial research into this company and role, maintained with this guide. Candidate-reported, not an employer publication.
PracHub page · Accessed 2026-09-22 - 02PracHub Data Scientist practice ↗
Cross-company practice questions for this role.
PracHub page · Accessed 2026-09-22 - 03PracHub interview preparation framework ↗
The framework the preparation plan follows.
PracHub page · Accessed 2026-09-22
Explore related engineering environments and compare the preparation focus.
Veracyte Data Scientist Interview Questions & Guide 2026
Causal-inference exercises for Veracyte data scientist prep: difference-in-differences, matching, instrumental variables, and knowing when observational data simply cannot answer the question asked.
Zoetis Data Scientist Interview Questions & Guide 2026
Metric-diagnosis practice for Zoetis data scientist candidates: a number moves week over week and you work out why, splitting by segment, ruling out a logging or release change, and separating a mix shift from a real change in user behaviou
Vizient Data Scientist Interview Questions & Guide 2026
Communication practice for Vizient data scientist candidates: turn an analysis into a recommendation, name the uncertainty honestly, and answer the follow-up a skeptical stakeholder will raise.
Vibrant Emotional Health Data Scientist Interview Questions & Guide 2026
Case practice for the Vibrant Emotional Health data scientist interview, where the prompt is deliberately underspecified and your first move is scoping it into something measurable.